The FDA-approved GLP-1 receptor agonists are exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and efpeglenatide (Eperzan)
A 2024 KFF study found Medicaid coverage could benefit 40% of adults and 26% of children with obesity, forcing policymakers to weigh cost, equity and long-term health outcomes as demand grows and new uses emerge
Ignore social media advice unless it is coming from a qualified expert
Just discontinue the medication as soon as possible
His experience includes a blend of qualitative and quantitative investment roles at Two Sigma, Norges Bank Investment Management, and Citadel
The established urinary threshold level of 150 g/mL may be reached (rarely, but possibly) in some individuals within 6-20 hours of taking some long-acting therapeutic formulations